DrugPatentWatch Database Preview
Details for Patent: 8,865,698
» See Plans and Pricing
Which drugs does patent 8,865,698 protect, and when does it expire?
Patent 8,865,698 protects VITRAKVI and is included in two NDAs.
This patent has ninety-five patent family members in thirty-five countries.
Summary for Patent: 8,865,698
Title: | Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds |
Abstract: | Provided herein are methods for treating pain, cancer, inflammation, neurodegenerative disease or Typanosoma cruzi infection in a mammal, which comprises administering to said mammal in need thereof a therapeutically effective amount of a compound of Formula I: ##STR00001## in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, X, Y and n have the meanings given in the specification. |
Inventor(s): | Haas; Julia (Boulder, CO), Andrews; Steven W. (Boulder, CO), Jiang; Yutong (Boulder, CO), Zhang; Gan (Niwot, CO) |
Assignee: | Array BioPharma Inc. (Boulder, CO) |
Application Number: | 13/943,590 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,865,698
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Hlthcare | VITRAKVI | larotrectinib sulfate | CAPSULE;ORAL | 210861-001 | Nov 26, 2018 | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||||
Bayer Hlthcare | VITRAKVI | larotrectinib sulfate | CAPSULE;ORAL | 210861-002 | Nov 26, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||||
Bayer Healthcare | VITRAKVI | larotrectinib sulfate | SOLUTION;ORAL | 211710-001 | Nov 26, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,865,698
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 074052 | Start Trial | |||
Argentina | 112833 | Start Trial | |||
Australia | 2009308465 | Start Trial | |||
Australia | 2015200511 | Start Trial | |||
Australia | 2017268517 | Start Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |